Monash University is Australia’s leading university in medical engineering.

Our multidisciplinary teams of researchers, together with top clinicians in our partner hospitals, are creating innovative medical technologies for the heart, lung, brain and vision.

The Monash Institute of Medical Engineering (MIME), fosters and coordinates translational medtech research across Monash University faculties, partner hospitals and collaborating medical research institutions. Our clinician-led research programs focus on major clinical and health system needs, and integrate expertise from across engineering, IT, science, biomedical and clinical research to develop new devices, diagnostics, therapeutics, delivery systems and clinical tools.

Our two major clinical nodes are based at the Alfred Medical Research and Education Precinct and the Monash Health Translation Precinct, and our headquarters is in the New Horizons building on the Monash Clayton campus. We work in close partnership with industry and hospitals to accelerate the development of new technologies through development, trials, commercialisation and adoption.

Latest news

Monash University news

Breathing new life into asthma treatment using the palm of their hand

World-first drug delivery technology, designed by Monash University researchers to help improve the health of asthmatics, has received a grant of more than $725,000 through the Federal Government’s National Health and Medical Research Council (NHMRC).

Opening eyes to a frontier in vision restoration

Monash University news

A revolutionary cortical vision device, developed by Monash University researchers that could one day help restore vision to the blind, is being prepared for world-first human clinical trials in Melbourne.

Simulation-based training to aid artificial heart and lung patients

A project focused on providing simulation-based training models to trainee doctors aims to reduce the risks of complicated procedures and save patients’ lives.

Personalised aerosol drug delivery to aid in respiratory disease

A new respiratory drug delivery technology, supported by the Monash Institute of Medical Engineering and SPARK Oceania, will aim to target different regions of the airway specific to the disease to be treated.

Monash University news

MIME Seed Funding applications now open - Practical solutions for frontline clinical problems

Applications for the 2020 round of MIME Seed Funding are now open!

View more articles